Thousand Oaks, CA, United States of America

Kasper Friis

This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Amgen Inc.. Active years: 2023-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kasper Friis. Retrieved from https://idiyas.com/inventor/kasper-friis-tgnpl4ly

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 49(Granted Patents)


Company Filing History:


Years Active: 2023-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Kasper Friis

Introduction

Kasper Friis is an accomplished inventor based in Thousand Oaks, CA. He has made significant contributions to the field of drug delivery systems, holding a total of 2 patents. His work focuses on developing innovative solutions that enhance the effectiveness of medical treatments.

Latest Patents

Among his latest inventions is a handheld drug delivery device. This device is designed to improve the administration of medications, making it more convenient for patients. The handheld nature of the device allows for ease of use, which is crucial in medical settings.

Career Highlights

Kasper Friis is currently employed at Amgen Inc., a leading biotechnology company. His role at Amgen allows him to work on cutting-edge technologies that have the potential to transform patient care. His dedication to innovation is evident in his patent contributions.

Collaborations

Throughout his career, Kasper has collaborated with notable colleagues, including Emil Finkelstein and Lars Eilertsen. These partnerships have fostered a creative environment that encourages the development of groundbreaking medical technologies.

Conclusion

Kasper Friis exemplifies the spirit of innovation in the medical field through his patents and work at Amgen Inc. His contributions are paving the way for advancements in drug delivery systems, ultimately benefiting patients and healthcare providers alike.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…